Sintx Technologies (SINT) Income from Continuing Operations (2013 - 2026)
Sintx Technologies' (SINT) quarterly Income from Continuing Operations came in at 2821000.0 in Q1 2026, down 23.08% year-on-year from 3667460.01 in Q1 2025, and down 27.36% quarter-over-quarter from 2215000.0 in Q4 2025.
Sintx Technologies (SINT) Income from Continuing Operations (2013 - 2026) Analysis & Trends
Sintx Technologies' Income from Continuing Operations history runs 14 years deep, the most recent figure standing at 2821000.0 for Q1 2026.
- On a quarterly basis, Income from Continuing Operations fell 23.08% year-over-year to 2821000.0 in Q1 2026; TTM through Mar 2026 was 10893000.0, a 12.37% increase from a year earlier, with the FY2025 full-year figure at 8188000.0, up 21.34% from the prior year.
- Income from Continuing Operations eased to 2821000.0 in Q1 2026 per SINT's latest filing, from 2215000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 293000.0 in Q1 2023 and bottomed at 6239000.0 in Q3 2024.
- The 5-year median for Income from Continuing Operations is 2455000.0 (2023), against an average of 2618058.82.
- Across the five-year window, Income from Continuing Operations surged 89.7% in 2023 and tumbled 202.39% in 2024, its largest moves.
- Year by year, Income from Continuing Operations stood at 3958000.0 in 2022, then soared by 41.36% to 2321000.0 in 2023, then increased by 26.97% to 1695000.0 in 2024, then slumped by 30.68% to 2215000.0 in 2025, then decreased by 27.36% to 2821000.0 in 2026.
- Per Business Quant, the three latest SINT Income from Continuing Operations figures stand at 2821000.0 (Q1 2026), 2215000.0 (Q4 2025), and 3539000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 273.95 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Sintx Technologies | 17,274.80 | -1.87 Mn | 144,000.00 | -2.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.82 Mn |
| Dec 31, 2025 | -2.22 Mn |
| Sep 30, 2025 | -3.54 Mn |
| Jun 30, 2025 | -2.32 Mn |
| Mar 31, 2025 | -2.29 Mn |
| Dec 31, 2024 | -1.70 Mn |
| Sep 30, 2024 | -6.24 Mn |
| Jun 30, 2024 | -2.20 Mn |
| Mar 31, 2024 | -886,000.00 |
| Dec 31, 2023 | -2.32 Mn |
| Sep 30, 2023 | -3.19 Mn |
| Jun 30, 2023 | -2.46 Mn |
| Mar 31, 2023 | -293,000.00 |
| Dec 31, 2022 | -3.96 Mn |
| Sep 30, 2022 | -2.72 Mn |
| Jun 30, 2022 | -2.51 Mn |
| Mar 31, 2022 | -2.85 Mn |
| Dec 31, 2021 | -2.13 Mn |
| Sep 30, 2021 | -2.34 Mn |
| Jun 30, 2021 | -2.20 Mn |